Background: prescribing for older people is a complex process and can elevate the risk of inappropriate prescribing, with potentially severe consequences. With a growing ageing population, strategies to improve prescribing in care homes are essential. Our aim was to review systematically the effects of interventions to optimise prescribing in care homes. Method: databases searched were MEDLINE, EMBASE, International Pharmaceutical Abstracts and the Cochrane Library from 1990. Search terms included were 'nursing home', 'residential home', 'inappropriate prescribing', 'education' and 'intervention'. Two independent reviewers undertook screening and methodological quality assessment, using the Downs and Black rating scale. Results: the search strategy retrieved 16 studies that met the inclusion criteria. Four intervention strategies were identified: staff education, multi-disciplinary team (MDT) meetings, pharmacist medication reviews and computerised clinical decision support systems (CDSSs). Complex educational programmes that focused on improving patients' behavioural management and drug prescribing were the most studied area, with six of eight studies highlighting an improvement in prescribing. Mixed results were found for pharmacist interventions. CDSSs were evaluated in two studies, with one showing a significant improvement in appropriate drug orders. Two of three studies examining MDT meetings found an overall improvement in appropriate prescribing. A meta-analysis could not be performed due to heterogeneity in the outcome measures. Conclusion: results are mixed and there is no one interventional strategy that has proved to be effective. Nevertheless, education including academic detailing seems to show most promise. A multi-faceted approach and clearer policy guidelines are likely to be required to improve prescribing for these vulnerable patients.
Introduction
Prescribing in older people is a complex process. Older people often have multiple co-morbidities, age-related pharmacokinetic and pharmacodynamic changes and polypharmacy [1] . Drug safety profiles may have improved in modern medicines provided drugs are prescribed and used appropriately. However, randomised controlled trials of drug treatment for common conditions in the elderly often focus on a single-disease process; they often do not take into account co-morbidities and other factors that may affect the response to treatment; for example, drug-drug interactions and the effect of the drug on other disease processes [2] .
Older people are prescribed more medication than younger people. In England, for instance, while younger people received an average of 9.5 items per year, people aged 60 and over received an average of 42.4 items in 2007 [3] . This almost doubled over a 10 year period; the corresponding figure in 1997 was 22 .3 prescription items [3] . With a growing older population, use of prescription medication is projected to rise further as chronic conditions, such as diabetes and hypertension will require more intensive therapy. These high levels of medication use may lead to increased risk of inappropriate prescribing (IP).
Care home patients are particularly vulnerable to IP: they are more fragile, unable to detect errors in their prescriptions and receive interventions from multiple sources [4] . These patients are therefore at risk of sub-optimal prescribing, particularly overprescribing, receiving up to four times as many prescriptions compared with older people living in the community [5] and prone to 'prescribing cascades' [6] . In the UK, the average number of medications taken at one time by care home residents is between six and seven, with over 20% of patients using more than 10 medications [7] [8] [9] . IP in care homes is commonly associated with adverse drug reactions, hospital admissions, mortality and unnecessary health care utilisation [9, 10] . With 16% of the population over the age of 65 and an estimated 410,000 older people living in UK nursing and residential homes [11] , improving prescribing quality in care homes is important.
While there is evidence on interventions to minimise IP in hospitals, outpatient settings and primary care, little has been done to evaluate interventions in care homes. Reviews have been published in recent years on interventions designed to reduce IP in older people [12, 13] and one has examined pharmacists' interventions to optimise medication use in nursing homes [13] . The purpose of our review was to interpret the results of studies that have evaluated any type of strategy to improve prescribing in care homes. This is the first systematic review examining a range of different types of interventions solely based in care home settings.
Methods

Data sources and search strategy
The search strategy aimed to retrieve papers on interventions to improve prescribing in care homes (residential, nursing and mixed homes; defined in Supplementary data, available in Age and Ageing online). Databases used were OVIDSP (MEDLINE and EMBASE), International Pharmaceutical Abstracts and the Cochrane Library. We combined three groups of keywords: those relating to the care home setting, those relating to IP and those relating to interventions (Figure 1 ). All retrieved articles were initially reviewed by title and abstract to find potentially relevant papers. The reference lists for articles that met the inclusion criteria were then reviewed to identify any further papers.
Study selection
Selected papers were assessed against the following inclusion criteria: (i) randomised or non-randomised controlled studies; (ii) residents' mean age ≥65; (iii) care homebased setting; (iv) evaluated the effect of an intervention on prescribing, aimed at improving appropriate prescribing or reducing IP; (v) written in English; (vi) published between 1990 and April 2010. Studies published only as abstracts were excluded. In this review, IP in older people was defined as (i) use of medicines that pose more risk than benefit ( particularly when safer alternatives exist); (ii) prescribing of inappropriate dose or duration of drugs; (iii) presence of clinically significant drug-drug and drugdisease interactions; (iv) under-use of potentially beneficial medications (v) or duplication of agents [14] .
Data extraction and quality assessment
Two reviewers performed the search and then screened the titles and abstracts independently to identify studies that met the inclusion criteria. Any discrepancies were resolved by discussion or a third independent reviewer. Relevant full text articles were then reviewed to extract specific details. Outcome measures were examined to assess whether a meta-analysis could be performed.
A quality assessment was conducted for each study using a modification of the Downs and Black tool [15] . The published tool comprises 27 items with a maximum score of 32; the last item evaluating the power of the study is scored out of 5. However, in line with previous studies [16] , this was omitted due to its potential ambiguity; hence, the maximum score in our review was 27. Scoring was completed by two independent reviewers and discrepancies were resolved through discussion or by a third independent reviewer. Higher scores reflected better study quality.
Results
A total of 512 articles were identified, of which 16 met the inclusion criteria. Studies were conducted in nursing homes, residential homes, long-term care facilities and mixed homes. Overlaps between some of the interventions exist. However, for the purpose of this review, interventions were grouped into one of the following four groups; staff education ( prescribers and/or care home staff; n = 8), multi-disciplinary team (MDT) meetings (usually chaired by the prescribing physician; n = 3), pharmacist medication reviews (n = 3) and computerised clinical decision support systems (CDSSs; n = 2). Mean quality scores are presented in Supplementary data, available in Age and Ageing online; studies were generally of high quality with mean scores of 20 and above. Two had much lower scores, one due to potential selection bias [17] and one due to potential confounding in a partially controlled before-and-after study [18] . Meta-analysis could not be performed due to heterogeneity in the outcomes measured.
Staff education
Eight studies (Table 1 ) reviewed the impact of educational interventions; six showed statistically significant improvements in prescribing quality [18] [19] [20] [21] [22] [23] . Academic detailing was used in six of the eight studies, sometimes combined with additional strategies. This is an educational outreach programme by an expert, involving face-to-face education with prescribers to discuss relevant clinical practice. [19] [20] [21] . They reported decreased numbers of residents on neuroleptics, reduced antipsychotic doses and reduced days on antipsychotics, respectively. Eide et al.
(Norway), in their before-and-after study with additional post-intervention concurrent controls, described the effects of a pharmacist-led education programme on the prescribing of hypnotics [18] . Of six outcome measures assessed, only one showed a significant improvement. Avorn et al.
(USA) focused on geriatric psychopharmacology, where a comprehensive educational outreach programme led by a pharmacist focused on reducing the overall use of psychotics by improving the selectivity of their use [22] . The intervention resulted in decreased mean psychoactive drug use [24] , which focused on falls and stroke prevention using pharmacist-led education, or Rovner et al. (USA) [25] which evaluated the effect of educational round by a psychiatrist, resulted in statistically significant changes in prescribing.
Pharmacist medication reviews
Three studies (Table 2 ) investigated the impact of pharmacist-led interventions on prescribing [26] [27] [28] . Various strategies were used: a single medication review plus consultation with carer and patient, and a clinical pharmacy programme utilising a number of different interventions. Only one of the studies reported statistically significant changes: Zermansky et al. (UK) assessed effects of a clinical medication review and reported significant changes in the number and type of medication (medications discontinued and commenced), but the total number of medications used remained the same.
Furniss et al. (UK) examined the effects of medication review by a pharmacist and assessed appropriateness of prescribing of neuroleptics based on the USA's Omnibus Reconciliation Act (OBRA) 1987 guidelines [27] . There was a decline in the number of drugs prescribed with corresponding savings in drug costs, although this was not statistically different. Roberts et al. (Australia) examined the impact of a clinical pharmacy programme [28] . The intervention was threefold; relationship building with stakeholders, nurse education, and medication review by clinical pharmacists. No significant differences in drug use (total drugs and subcategories) or morbidity indices (hospitalisation rates, adverse drug events) were identified.
Multi-disciplinary team meetings
Three studies (Table 2 ) evaluated the effect of MDT meetings on prescribing and two showed statistically significant findings [29, 30] .
With a sample representing 5% of Swedish nursing homes, Schmidt et al. examined the impact of monthly MDT meetings on adherence to the 1994 Swedish Medical Product Agency (SMPA) prescribing guidelines [29] . The SMPA guidelines, which provide recommendations on the use of psychotropics, were available to all physicians in Sweden but were actively distributed to physicians in the intervention homes. The intervention resulted in a significant decrease in the prescribing of several psychoactive drugs. Crotty et al. (Australia) conducted MDT meetings in the presence of a representative from the Alzheimer's Association of South Australia. The Medication Appropriateness Index (MAI) was used to assess the appropriateness of medication [30] . A within-facility control was also set up to assess any 'carry-over' effect. A significant improvement in appropriateness of prescribing and no evidence of 'carry-over' effect to other residents were demonstrated in the intervention homes.
King et al. (Australia) carried out a controlled before-and-after study where cases for discussion were selected by their GPs who then led a 30 min case discussion and management plan. No significant changes were reported in medication use, cost and mortality [17] .
Computerised clinical decision support systems
Two studies (Table 2 ) evaluated the effects of CDSSs on prescribing in the elderly [31, 32] . One examined the effect of a CDSS on the appropriateness of drug orders in patients with renal insufficiency in Canada, and identified significantly more appropriate drug orders [31] .
Gurwitz et al. (USA) identified no effects on the overall number of adverse drug events after implementation of a CDSS for 12 months [32] .
Discussion
We identified 16 studies, grouped into one of four categories. Only one study used more than one intervention [28] , although we categorised it as pharmacist review since this was the main component of the intervention. Multi-faceted interventions may be expected to be more powerful than using individual tools alone [33] .
Staff education
Staff education, especially academic detailing, has the strongest evidence, with half of the studies having evaluated this intervention strategy and six of eight showing improvements in prescribing. The six 'successful' studies employed interactive techniques: academic detailing with face-to-face interaction between the prescribing physician and a group of experts, workshops for nurses, and family education. This review found that educating both physicians and nurses proved to be effective; previous work demonstrated that educating physicians alone was not as effective [34] . Two studies did not show any significant improvement in prescribing quality [24, 25] . Crotty et al. presented physicians with stroke management and psychotropic use guidelines together with audit results [24] . Audits' limited effect is consistent with a Cochrane review which showed that audit and feedback have only a small to moderate impact on professional practice and healthcare outcomes [35] . Other limitations in the study, when compared with the more 'successful' studies, were fewer educational sessions and poor attendance by participating GPs. Rovner et al. had several flaws in their study design. The study had a small sample size and was conducted in a single 250-bed intermediate-level nursing home with risk of 'cross-over' effects between control and intervention groups [25] . Only significant improvement in prescribing described.
Computerised clinical decision support systems
There is considerable literature on the value of CDSSs. Evidence from US hospital settings suggests that drug safety can be improved by computerised physician order entry (CPOE) with CDSS [36] . One of the two studies that examined the effect of CDSS showed a positive effect, although the extent of the intervention might have been underestimated as study physicians cared for both control and intervention patients. The Gurwitz study [32] showed no significant difference in the rate of adverse drug events with CDSS; however, adverse drug events are rarer than inappropriate orders and as such differences are likely to be more difficult to detect. The CPOE system was also reported as not able to calculate total daily dose [32] and hence the high number of false alerts in the CPOE system may have led to 'alert fatigue', where the prescriber starts to ignore the alerts [37].
Multi-disciplinary team meetings
MDT meetings are commonly used to improve communication among healthcare professionals, and to optimise patient care. Of the three studies, those by Crotty et al. [30] and Schmidt et al. [29] found statistically significant changes in medication-related outcomes. Selection bias could have possibly been introduced in King et al.'s [17] study, where patients were selected for MDT discussion by their primary care physician. Staff involved in the MDT meetings also cared for control patients, possibly affecting their care. Moreover, with one month follow-up, this gives no indication of the long-term impact of the intervention.
Pharmacist medication reviews
The UK's National Service Framework for Older People recommends that patients taking four or more drugs be reviewed six-monthly, with the remainder, annually [38] . The value of a pharmacist in conducting regular medication reviews to reduce IP in hospitals is well established [39] [40] [41] and similar results were anticipated in care homes. However, only one of three studies demonstrated a significant effect of pharmacists' interventions on prescribing. This may partly be due to the inappropriate choice of outcome measures. Roberts et al. and Furniss et al., for example, used the change in the number of medications as a primary outcome measure. Although with increased number of medications, there is greater likelihood of adverse drug reactions, polypharmacy does not always reflect appropriateness of prescribing, as the initiation of some medications may be clinically indicated [42] .
Choice of outcome measures
Outcome measures varied considerably with a number of authors interpreting a reduction in the total number of medication as an improvement in prescribing, which may not always be true. One of the UK-based studies used the US OBRA guidelines to assess appropriateness of prescribing. Others have used national or good practice guidelines. One used MAI but interestingly, none used Beer's criteria [43] , a USA-based tool commonly used to assess IP in nursing homes.
Limitations of review
Categorisation of articles was not always straightforward. For instance, academic detailing by pharmacists who reviewed case notes and identified points for discussion as part of an outreach programme was categorised as staff education and not pharmacist medication review [18, 22, 24 ]. Rovner's study could potentially be classified as management by a specialist combined with MDT meetings [25] , but was classified as an educational intervention. In addition, with a limited number of articles, some of which targeted psychosocial interventions more than pharmacotherapy (e.g. behavioural management more than improving prescribing), it is challenging to synthesise the evidence for improved prescribing in care homes [19, 21, 25] . The limited search terms and limit to the English language mean that this systematic review has its limitations. For instance, unless a quality improvement effort was indexed as an intervention, it would have been missed. The types of studies that we had aimed to retrieve have also been subjected to publication bias. Some studies may be considered 'old', because prescribing guidelines and doctors' training have evolved; however, we believe their strategies are still relevant.
Lastly, we acknowledge the difficulty in generalising findings from one country to another, due to differences in definitions, nature of personnel training and supervision of drug therapy.
Implications for policy and practice
For educational interventions to be effective, tailored programmes that employ several complementary techniques may be needed; academic detailing with educational reinforcement and follow-up should be directed at all healthcare professionals and possibly family members. Educational interventions can be easy and effective to implement as the knowledge gained is not patient-specific. Sustainability is supported if 'in-house training' is an option, as this will enable GPs to be regularly updated. Conversely, CPOE-CDSS is resource-intensive which may restrict its applicability in care homes.
Monthly pharmacist medication review is mandatory in the USA to improve prescribing in care homes; this has also been proposed for the UK [4] . In our review, MDT meetings [29, 30] as well as staff education [22, 24] involving pharmacists proved successful despite insufficient evidence for pharmacist-led reviews alone. Beneficial effects have been documented in hospitals and may be transferable to care homes, given sufficient pharmacist resource.
With those aged 65 and over predicted to account for 22% of the population by 2033, there needs to be clear guidelines for prescribing. The OBRA 1987 created a set of USA national minimum standards of care and rights for people living in certified nursing facilities [44] . We propose that UK policy be directed to improve the quality of prescribing in care homes based on results of controlled trials. Standardised measurements for measuring IP are also needed to enable effective benchmarking. Finally, we recommend that a combination of two or more interventional strategies is explored to improve prescribing in this population.
Conclusion
Improving prescribing in care homes is complex and there is limited evidence for effective interventions. This review demonstrated mixed results with substantial evidence and promising options for some of the interventions. Education including academic detailing seems to show most promise. Combinations of intervention strategies are likely to be required.
Key points
• There is limited evidence for most interventions but education including academic detailing seems to show most promise.
• Combinations of intervention strategies are likely to be required.
• Standardised measures for IP are needed to facilitate comparison across studies.
